Results 31 to 40 of about 2,024,119 (265)

Universal screening for meticillin-resistant Staphylococcus aureus : interim results from the NHS Scotland pathfinder project [PDF]

, 2009
Following recommendations from a Health Technology Assessment (HTA), a prospective cohort study of meticillin-resistant Staphylococcus aureus (MRSA) screening of all admissions (N = 29 690) to six acute hospitals in three regions in Scotland indicated ...
Masterton, R., Allardice, G., Williams, C., Smith, A., Stewart, S., Gould, I.M., Christie, P., Scottish Government Health Directorate (Funder), Reilly, J.S.   +8 more
core   +4 more sources

Impact of target site distribution for Type I restriction enzymes on the evolution of methicillin-resistant Staphylococcus aureus (MRSA) populations. [PDF]

, 2013
A limited number of Methicillin-resistant Staphylococcus aureus (MRSA) clones are responsible for MRSA infections worldwide, and those of different lineages carry unique Type I restriction-modification (RM) variants.
Dryden, David T. F., White, John H., Stephanou, AS, Cooper, Laurie P., Cooper, LP, Houston, PJ, Lindsay, JA, Chen, K, Dryden, DT, Roberts, Gareth A., Lindsay, Jodi A., Chen, Kai, Roberts, GA, White, JH, Stephanou, Augoustinos S., Houston, Patrick J.   +15 more
core   +1 more source

Screening strategies in surveillance and control of methicillin-resistant Staphylococcus aureus (MRSA) [PDF]

, 2006
With reports of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) continuing to increase and therapeutic options decrease, infection control methods are of increasing importance.
Jenkins, D. R., Robotham, Julie, Medley, Graham   +2 more
core   +1 more source

Building a genomic framework for prospective MRSA surveillance in the United Kingdom and the Republic of Ireland [PDF]

, 2015
The study was supported by grants from the UKCRC Translational Infection Research Initiative, and the Medical Research Council Grant Number G1000803) with contributions to the Grant from the Biotechnology and Biological Sciences Research Council, the ...
Holden, MTG, Raven, Kathy E, Feil, EJ, Feil, Edward J, Raven, Kathy E., Donker, Tjibbe, Holden, Matthew T G, Bentley, SD, Estee Torok, M., Reuter, Sandra, Spratt, BG, Aanensen, David M, Török, M Estée, Parkhill, J, Holden, Matthew TG, Reuter, S, Blane, B, Aanensen, David M., Spratt, Brian G, Toeroek, ME, Blane, Beth, Bentley, Stephen D, Grundmann, H, Aanensen, DM, Toeroek, M. Estee, Reynolds, Rosy, Bentley, Stephen D., Török, Estee M, Holden, Matthew T. G., Feil, Edward J., Peacock, Sharon J., Grundmann, Hajo, Reynolds, R, Peacock, SJ, Raven, KE, Spratt, Brian G., Parkhill, Julian, Peacock, Sharon J, Donker, T   +38 more
core   +4 more sources

Azithromycin-loaded liposomal hydrogel: a step forward for enhanced treatment of MRSA-related skin infections

Acta Pharmaceutica, 2023
Azithromycin (AZT) encapsulated into various types of liposomes (AZT-liposomes) displayed pronounced in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA) (1).
Rukavina Zora, Jøraholmen May Wenche, Božić Dunja, Frankol Ivana, Gašparović Petra Golja, Škalko-Basnet Nataša, Klarić Maja Šegvić, Vanić Željka   +7 more
doaj   +1 more source

Genetic Variation in Spatio-Temporal Confined USA300 Community-Associated MRSA Isolates: A Shift from Clonal Dispersion to Genetic Evolution? [PDF]

, 2011
NTRODUCTION: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are increasingly isolated, with USA300-0114 being the predominant clone in the USA. Comparative whole genome sequencing of USA300 isolates collected in 2002, 2003 and
Fluit, AC, Bonten Marc J. M., Thomas W. Rice, Bonten, MJ, Jodi A. Lindsay, Rob J. L. Willems, Adam A. Witney, Rice, TW, Lindsay Jodi A., Carpaij Neeltje, Weinstein, RA, Hinds Jason, Marc J. M. Bonten, Robert A. Weinstein, Witney Adam A., Witney, AA, Weinstein Robert A., Ad C. Fluit, Carpaij, N, Willems, RJ, Lindsay, JA, Hinds, J, Fluit Ad C., Jason Hinds, Neeltje Carpaij, Rice Thomas W., Willems Rob J. L.   +26 more
core   +1 more source

In vitro anti-MRSA activity of carvone with gentamicin

Experimental and Therapeutic Medicine, 2014
Carvone is one of the naturally occurring monoterpenes, the largest class of secondary metabolites in plants, and exists in two enantiomers, R-carvone (R-car) and S-car. The objective of this study was to investigate the antimicrobial activity of R-car and S-car with gentamicin (GET) against methicillin-resistant Staphylococcus aureus (MRSA). MRSA is a
MUN, SU-HYUN, KANG, OK-HWA, JOUNG, DAE-KI, KIM, SUNG-BAE, CHOI, JANG-GI, SHIN, DONG-WON, KWON, DONG-YEUL   +6 more
openaire   +3 more sources

Novel Tricyclic Flavonoids as Promising Anti-MRSA Agents. [PDF]

Pharmaceuticals (Basel)
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is considered the main cause of nosocomial and community-associated infections. Because of antimicrobial resistance, MRSA infections are difficult or impossible to treat, leading to high mortality rates and significant economic and societal costs.
Moldovan CV, Mantea LE, Savu M, Jones PG, Sarbu LG, Stefan M, Birsa ML.   +6 more
europepmc   +4 more sources

Successful percutaneous retrieval of a micra transcatheter pacing system at 8 weeks after implantation

Journal of Arrhythmia, 2018
An 86‐year‐old woman suffering from repeated methicillin‐resistant Staphylococcus aureus (MRSA) bacteremia underwent percutaneous lead extraction using an excimer laser. Since negative blood cultures were confirmed three times after lead extraction under
Masatsugu Nozoe, Daisuke Yoshida, Daisuke Nagatomo, Nobuhiro Suematsu, Toru Kubota, Masanori Okabe, Yusuke Yamamoto   +6 more
doaj   +1 more source

Anti-MRSA Activity of Actinomycin X2 and Collismycin A Produced by Streptomyces globisporus WA5-2-37 From the Intestinal Tract of American Cockroach (Periplaneta americana)

Frontiers in Microbiology, 2020
Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as one of the serious pathogen that causes acquired infections worldwide. Its emerging need to discover novel, safe and potent anti-MRSA drugs. In this study, primary screening by anti-MRSA
Zhiyu Chen, Zhiyu Chen, Peiyu Ou, Peiyu Ou, Lingyan Liu, Lingyan Liu, Xiaobao Jin, Xiaobao Jin   +7 more
doaj   +1 more source